LOVD - Variant listings for RPS19

About this overview [Show]

Patient data (#0000167)
Patient ID pat1rps1900082
Gender f
Malformations Hypertelorism,epicanthus, low earset, antimongoloid eyeline
Growth Retardation no
Steroid Response na
Complications -
Variant Origin familial
Reference Draptchinskaia et al (1999) Nat Genet 21, 169-75
Template DNA, RNA
Technique SEQ
Remarks -
# Reported 1

Variant data
Allele Unknown
Reported pathogenicity Pathogenic
Concluded pathogenicity Pathogenic
Exon 05
DNA change deletion of 295bp spanning exon 5 (nt 357-411 of the cDNA)
RNA change -
Protein p.Gly120Trpfs
Frequency -
DB-ID RPS19_00082
Location -
Remarks Large deletion
Molecula Mechanisms -
Functional_Classific Reduces RPS19 mRNA levels
mRNA_Expression Reduced to 60% of controls (wt 50%-mutant 10%), aberrant mRNA is subjected to nonstop decay (lymphoblastoid cell lines) [1]
Protein_Expression -
Protein_Localization -
rRNA_Metabolism -
Protein_Synthesis -
Cell_Growth -
Functional_Remarks translation inhibition by cycloheximide stabilizes the mutant mRNA form, as expected in NMD and non stop decay
Functional_Reference [1] Chatr-Aryamontri et al (2004) Hum Mutat 24, 526-33

1 entry in RPS19

Path.
Allele Descending
Ascending
Exon Descending
Ascending
DNA change Descending
Ascending
RNA change Descending
Ascending
Protein Descending
Ascending
Frequency Descending
Ascending
DB-ID Descending
Ascending
Location Descending
Ascending
Remarks Descending
Ascending
Molecula Mechanisms Descending
Ascending
Functional_Classific Descending
Ascending
mRNA_Expression Descending
Ascending
Protein_Expression Descending
Ascending
Protein_Localization Descending
Ascending
rRNA_Metabolism Descending
Ascending
Protein_Synthesis Descending
Ascending
Cell_Growth Descending
Ascending
Functional_Remarks Descending
Ascending
Functional_Reference Descending
Ascending
+/+ Unknown 05 deletion of 295bp spanning exon 5 (nt 357-411 of the cDNA) - p.Gly120Trpfs - RPS19_00082 - Large deletion - Reduces RPS19 mRNA levels Reduced to 60% of controls (wt 50%-mutant 10%), aberrant mRNA is subjected to nonstop decay (lymphoblastoid cell lines) [1] - - - - - translation inhibition by cycloheximide stabilizes the mutant mRNA form, as expected in NMD and non stop decay [1] Chatr-Aryamontri et al (2004) Hum Mutat 24, 526-33